A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma-Reference-Cited by-同舟云学术

A Multicenter Trial of Infusional Etoposide, Doxorubicin, and Vincristine with Cyclophosphamide and Prednisone (EPOCH) in Patients with Relapsed Non-Hodgkin's Lymphoma

Published:2001-03 Issue:4 Volume:1 Page:285-292
ISSN:1526-9655
Container-title:Clinical Lymphoma
language:en
Short-container-title:Clinical Lymphoma

Author:

Wilder Diane D.,Ogden Julie L.,Jain Vinay K.

Publisher

Elsevier BV

Subject

Cancer Research

Reference18 articles.

1. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non- Hodgkin's lymphoma;Fisher;N Engl J Med,1993

2. Prognostic factors in non-Hodgkin's lymphoma;Shipp;Curr Opin Oncol,1992

3. Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP;Rodriguez;J Clin Oncol,1995

4. ESHAP - an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year followup study;Velasquez;J Clin Oncol,1994

5. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP);Velasquez;Blood,1988

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B Cell Lymphoma;Advances in Therapy;2020-10-01

2. In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag;Journal of Clinical Pharmacy and Therapeutics;2019-09-17

3. EPOCH regimen as salvage therapy for adult T-cell leukemia–lymphoma;International Journal of Hematology;2018-04-12

4. Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies;Cancer Investigation;2017-02-06

5. Proteasome inhibitors in mantle cell lymphoma;Best Practice & Research Clinical Haematology;2012-06